Arch Impex Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.46 Cr
as on 14-12-2024
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 39.45 Cr
as on 14-12-2024
- Revenue -8.95%
(FY 2022)
- Profit 156.78%
(FY 2022)
- Ebitda 43.00%
(FY 2022)
- Net Worth 6.56%
(FY 2022)
- Total Assets -0.39%
(FY 2022)
About Arch Impex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.46 Cr.
The company has closed loans amounting to ₹39.45 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ajit Kamath and Rajendra Kaimal serve as directors at the Company.
- CIN/LLPIN
U51900MH2000PTC127806
- Company No.
127806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2000
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arch Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Kamath  | Director | 19-Jul-2000 | Current |
| Rajendra Kaimal | Director | 17-Sep-2003 | Current |
Financial Performance and Corporate Structure Insights of Arch Impex.
Arch Impex Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.95% decrease. The company also saw a substantial improvement in profitability, with a 156.78% increase in profit. The company's net worth moved up by a moderate rise of 6.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arch Impex?
Unlock access to Arch Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Arch Agro Industries Private LimitedActive 13 years 6 months
Ajit Kamath and Rajendra Kaimal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Investments And Loans India Limited Creation Date: 18 Nov 2008 | ₹25.00 Cr | Satisfied |
Global Trade Finance Pvt. Ltd. Creation Date: 19 Mar 2004 | ₹14.45 Cr | Satisfied |
How Many Employees Work at Arch Impex?
Unlock and access historical data on people associated with Arch Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arch Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
